Carregant...
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
Aberrant DNA methylation is an epigenetic hallmark of melanoma, known to play important roles in melanoma formation and progression. Recent advances in genome-wide methylation methods have provided the means to identify differentially methylated genes, methylation signatures, and potential biomarker...
Guardat en:
| Publicat a: | Clin Epigenetics |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381063/ https://ncbi.nlm.nih.gov/pubmed/28396701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-017-0332-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|